AI is deeply impacting how biopharma companies operate in drug discovery and development. Deep Learning, the fastest growing segment of AI, enables accurate analytics that were considered too complex just a few years ago. This interactive panel discussion will feature experts to discuss how AI is impacting biopharma R&D in three areas: (a) drug discovery (b) clinical development and (c) translational medicine

Ability Level: All

Session ID: 503542